1 min read
Greenwich LifeSciences Shares Gain More Than 25% After Trial Poster News
Two posters at an upcoming medical event will cover FLAMINGO-01, the company’s Phase 3 cancer trial.

Greenwich LifeSciences, Inc. shares rose more than 25% Tuesday, Nov. 17, after the company disclosed that two posters about its FLAMINGO-01 Phase 3 cancer trial are scheduled for an upcoming medical event.
The company trades on Nasdaq as GLSI.